9) Transformational Medical Technologies
Abstract
Development of Platform Technologies: Continues efforts previously funded under the Transformational Medical Technologies Initiative. Platform Technologies are stand alone enabling technologies that support MCM development and when strategically aligned, provide a system of systems response capability to an adverse biological event - from the identification of an unknown pathogen to the development of an approved countermeasure ready for delivery to the Warfighter and the nation. The enabling technologies are divided into five platform areas: Pathogen Characterization, Target Identification, Countermeasure Discovery, Countermeasure Evaluation, and Bioinfomatics. Efforts focus on advanced technology and development activities for Platform Technologies to include the maturation of components that will begin the process of integrating a countermeasure response pipeline. Off-the-shelf technologies will be identified, evaluated, and refined to demonstrate the ability to provide drug development capabilities. Advanced manufacturing platforms will continue to mature and the technology application will focus on the type of specific therapeutics under development.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2014
- Source ID
- 42ff615dd5290a4b68122b5c49c4b17d